Agilent provides innovative new resource for detecting designer drugs

Designer drugs—formulated to circumvent existing definitions of illegal compounds—have long proved difficult to trace. But now these substances can be quickly identified and analyzed using a unique resource from Agilent’s GC/MS technologies.

Agilent this week introduced new application compendiums, along with an expanded version of its GC/MS Designer Drug Library. The only resource of its kind, the searchable library includes designer stimulants that are often marketed as “bath salts” as well as cannabinoids designed to mimic the effects of marijuana.

Used in collaboration with Agilent’s specialized GC/MS laboratory technologies, the new compendiums provide forensic practitioners, crime laboratories, and federal workplace drug-testing programs with cost-effective, end-to-end solutions for designer drug screening and analysis.

Agilent developed these compendiums, and the expanded GC/MS Designer Drug Library, in collaboration with NMS Labs.


For more information go to: